This study involved patients of both genders aged between 15-45 years who presented with one or more episodes of deep vein
thrombosis or pulmonary embolism.
USPRwire, Tue Oct 31 2017] Deep Vein
Thrombosis (DVT) - Pipeline Review, H2 2015 Summary Global Markets Direct s, Deep Vein
Thrombosis (DVT) - Pipeline Review, H2 2015, provides an overview of the Deep Vein
Thrombosis (DVT)s therapeutic pipeline.
ACR appropriateness criteria [R]: Suspected lower-extremity deep vein
A SCAFFOLDER died from deep vein
thrombosis a month after fracturing his leg on a London building site, an inquest heard.
Healthcare company Cardinal Health (NYSE:CAH) revealed on Friday the completion of the acquisition of Medtronic's Patient Care, Deep Vein
Thrombosis and Nutritional Insufficiency business for a purchase price of USD6.
In fact, deep vein
thrombosis (DVT) resulting in PE is a common cause of sudden death in patients who collapse, according to diagnostic and interventional radiologist Stephen Kee, MD, Ronald Reagan UCLA Medical Center.
Long periods spent sitting--behind a desk, in a car, on a long flight, or on a couch--increase the risk of deep vein
thrombosis (DVT), a blood clot that forms mainly in a deep vein
in the leg, which can lead to a pulmonary embolism, a condition that is often fatal.
The report forecasts the Venous Thromboembolism market containing deep vein
thrombosis and pulmonary embolism, to grow at a compound annual growth rate (CAGR) of 2.
Conclusion: Deep vein
thrombosis is the commonest cause of painful swollen leg in our population.
This is a long-lasting sore that can take up to nine months to heal because it has a very poor blood supply as a result of a deep vein
Global Markets Direct's, 'Deep Vein
Thrombosis (DVT) - Pipeline Review, H2 2015', provides an overview of the Deep Vein
Thrombosis (DVT)'s therapeutic pipeline.
Bayer HealthCare announced today the approval in Japan of its oral Factor Xa inhibitor Xarelto (rivaroxaban) for the treatment and secondary prevention of pulmonary thromboembolism and deep vein
thrombosis by the Japanese Ministry of Health, Labor and Welfare (MHLW).